Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma
2022 · BMC Cancer · 19 citations
https://doi.org/10.1186/s12885-022-09209-9
G
Guangbing Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
46
Papers
807
Citations
15
h-index
17
i10-index
Guangbing Li is an academic researcher from Shandong Provincial Hospital. The author has contributed to research in topics: Cholangiocarcinoma and Gallbladder Cancer Studies & Gallbladder and Bile Duct Disorders & Hepatocellular Carcinoma Treatment and Prognosis. The author has an h-index of 15, co-authored 40 publications.
ORCID: 0000-0002-1055-1944Papers by this author
worksElevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis
2024 · Cell Reports · 12 citations
https://doi.org/10.1016/j.celrep.2024.114431
GSK621 ameliorates lipid accumulation via AMPK pathways and reduces oxidative stress in hepatocytes in vitro and in obese mice in vivo
2025 · Life Sciences · 2 citations
https://doi.org/10.1016/j.lfs.2025.123687
Hypericin mediated photodynamic therapy induces ferroptosis via inhibiting the AKT/mTORC1/GPX4 axis in cholangiocarcinoma
2024 · Translational Oncology · 1 citations
https://doi.org/10.1016/j.tranon.2024.102234
Recent advance on diagnosis and treatment of solid pseudopapillary neoplasm of the pancreas
2026 · Journal of Pancreatology · 0 citations
https://doi.org/10.1097/jp9.0000000000000257
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat